Be Part of History: Join the Philippines' Case Series for Cellular Therapies
A National Effort to Transform Regenerative Medicine Access
Apply Now
About EXM: Advanced Placental Tissue Matrix
Next-Generation Regenerative Technology
EXM is a minimally processed extracellular matrix (allograft) designed to preserve the powerful regenerative elements found in postnatal human tissue. It supports the body's own healing mechanisms with:
Key Components
  • Mesenchymal Stem Cell (MSC) Components from 5 tissue sources
  • Natural Exosomes that aid cellular signaling
  • Structural Proteins & Growth Factors that rebuild tissue
Ethical U.S. Sourcing & Compliance
  • Collected from healthy cesarean donors in the U.S.
  • Fully screened and quarantined for 14 days
  • Manufactured in CLIA-certified, FDA-registered labs
  • 6 FDA audits passed with zero compliance issues
  • 21 CFR Part 1271 and AATB standards met
Why This Matters
Lead the path for legalized regenerative therapies in the Philippines
Build credibility for your clinic with regulatory agencies
Give your patients early access to safe, ethically sourced innovations
Regenerative Research Group Philippines (RRG PH) invites progressive medical clinics and doctors across the Philippines to participate in an exclusive Case Series for Cellular Therapies, as part of ongoing efforts to submit clinical evidence to the Philippine FDA and Department of Health. This initiative supports the advancement of regulations that will open the door for safer, ethical, and scientifically guided regenerative medicine throughout the country.
This initiative is not just research—it's a movement to bring healing technologies to the forefront of Philippine medicine.
Do Not Miss This Moment
Ongoing Trials Now Accepting Clinics
🔹 EXM (Advanced Placental Tissue Matrix) for Longevity, Joint Pain & Arthritis
🔹 MSC-Derived Exosomes for Facial Aesthetics & Skin Regeneration
Benefits of Joining
- Contribute to clinical data that may shape national guidelines
- Be recognized as an early pioneer in the legal use of cellular therapies
- Provide your patients with access to leading-edge regenerative treatments under investigational use
Support Provided
Clinics selected will receive training, documentation, and access to U.S.-made regenerative products for investigational use.
This Case Series is more than a clinical program—it's a landmark opportunity to reshape healthcare access, enhance professional standing, and directly impact patient outcomes.
📍 Limited to Philippine clinics only
📩 Apply now to join the national Case Series and help pioneer the future of regenerative medicine.